BRAUNOL Mucous membrane antiseptic, 20X250ml

Instructions for use for BRAUNOL Mucous membrane antiseptic, 20X250ml

Field of use

• The medicine is an antiseptic (germicidal agent) for use on skin, mucous membranes and wounds.
• For one-time use:
  • Disinfection of the intact external skin or antiseptic of the mucous membrane such as: B. before operations, biopsies, injections, punctures, blood samples and bladder catheterizations.
• For repeated, time-limited use:
  • Antiseptic wound treatment (e.g. pressure ulcers, leg ulcers), burns, infected and superinfected skin diseases.
• Hygienic and surgical hand disinfection.

Active ingredients / ingredients / ingredients

75 mg povidone iodine
7.5 mg iodine
Sodium dihydrogen phosphate 2-water excipient (+)
Sodium hydroxide excipient (+)
0.2 g sodium iodate excipient (+)
Polidocanol 600 excipient (+)
Water, purified excipient (+)

Contraindications

• The medicine must not be used,
  • if you are sensitive (allergic) to povidone-iodine or any of the other ingredients.
  • if you suffer from an overactive thyroid (hyperthyroidism) or another existing (manifest) thyroid disease,
  • if you suffer from the very rare chronic skin inflammation dermatitis herpetiformis Duhring,
  • if you have had radiotherapy of the thyroid gland with iodine (radioiodine therapy) planned or carried out (until treatment is completed).
  • for very small premature babies (birth weight less than 1500 g)

dosage

• Always use the product exactly as directed. Please ask your doctor or pharmacist if you are not sure.
• For skin disinfection or antiseptic of the mucous membrane, e.g. B. before surgical procedures, biopsies, injections, punctures, blood samples, bladder catheterizations, the preparation should be used undiluted.
• For skin disinfection of skin with few sebum glands, the exposure time is at least 15 seconds, for skin rich in sebaceous glands it is at least 10 minutes. The skin should be kept moist with the undiluted preparation throughout the entire exposure time.
• During preoperative skin disinfection, “puddle formation” under the patient must be avoided due to possible skin irritation.
• The medicine should be used undiluted for hand disinfection.
• For hygienic hand disinfection, 3 ml is rubbed into the hands. Wash hands after exposure for 1 minute.
• For surgical hand disinfection, 2 x 5 ml are rubbed into the hands for an exposure time of 5 minutes. Hands must be kept moist with the undiluted preparation throughout the entire exposure time.
• For the antiseptic treatment of superficial wounds, the medicine is applied undiluted to the areas to be treated.
• The solution can be diluted for antiseptic rinses, washes and baths.
  • The following dilutions are recommended as guidelines:
    • Rinsing as part of wound treatment (e.g. decubitus, leg ulcers, gangrene) and perioperative infection prophylaxis 1:2 to 1:20
    • Antiseptic washes 1:2 to 1:25
    • Antiseptic partial baths approx. 1:25
    • Antiseptic full baths approx. 1:100

 

 

• Frequency and duration of use
  • If used repeatedly, the frequency and duration of use depends on the indication.
  • The medicine can be used once or several times a day.
  • Wound treatment should be continued as long as there are still signs of infection or a clear risk of infection in the wound conditions. If your symptoms have not improved after regular use for several days (2 to 5 days), or if symptoms recur after treatment has been completed, please consult your doctor.

 

 

• If you have any further questions about using the medicine, ask your doctor or pharmacist.

Intake

• The medicine is intended for external use undiluted and in dilutions.
• The medicine should be applied to the area to be treated until it is completely wetted. The antiseptic film that forms when it dries can be easily washed off with water.
• Normal tap water is suitable for dilution. If approximate isotonicity is desired, physiological saline or Ringer's solution can be used. The dilutions should always be made fresh and used as soon as possible.
• To prepare antiseptic baths, water should first be poured into the tub and then the required amount of medication to avoid discoloration of the tub due to the development of fumes containing iodine.
• The brown color of the drug is a property of the preparation and indicates its effectiveness. Extensive discoloration indicates that the effectiveness of the preparation has been exhausted.

Patient information

• Particular caution when using the drug is required:
  • After thyroid disease or in the case of goiter, you should only use it over a longer period of time and over large areas (e.g. over 10% of the body surface and longer than 14 days) if the doctor has expressly instructed you. Even after therapy has ended (up to 3 months), attention should be paid to early symptoms of possible hyperthyroidism and thyroid function should be monitored if necessary.
  • If lithium therapy is used at the same time, regular use of the drug should be avoided
  • Because of the oxidizing effect of the active ingredient povidone-iodine, various diagnostic agents can produce false positive results during treatment with the drug (including toluidine and guaiac resin for hemoglobin)
    Determination of glucose in stool or urine).
  • Povidone-iodine can influence the iodine uptake of the thyroid; This can lead to disruptions in diagnostic examinations of the thyroid (thyroid scintigraphy, PBI-determination, radioiodine diagnostics) during treatment with the drug and make planned radioiodine therapy impossible. Before a new scintigram is taken, an interval of at least 1 - 2 weeks should be maintained after discontinuation of treatment with the drug
  • Children:
    • Avoid repeated use in newborns. After using the preparation, a check of thyroid function is necessary.
    • Accidental ingestion by the infant through the mouth must be avoided at all costs.
  • Older people:
    • The risk of hyperthyroidism caused by iodine is increased in older people. You should therefore only use the medicine after consulting your doctor. In older patients with goiter or a particular predisposition to thyroid dysfunction, large-scale and long-term use of the drug should only be carried out on the express instructions of the doctor. If necessary, thyroid function should be monitored.

Pregnancy

• Pregnancy
  • During pregnancy and breastfeeding, the medicine should only be used on the express instructions of the doctor and in an extremely limited manner. In this case, a check of the child's thyroid function is necessary.
• Lactation
  • Accidental ingestion of the drug by the infant with its mouth on the breast of the nursing mother must be avoided at all costs.

Hints

Miscellaneous

- Dilutions should always be made fresh and used as soon as possible.
- The brown color of povidone-iodine is a property of the drug and indicates its effectiveness. Extensive discoloration indicates exhaustion of the drug's effectiveness.

Therapy monitoring/control measures:
- After using the drug, a check of thyroid function is indicated in infants and small children. In the case of hypothyroidism, early treatment with thyroid hormones should be carried out until thyroid function returns to normal.

Influencing laboratory parameters.
- Due to the oxidizing effect of the active ingredient, various test agents can produce false-positive results during treatment with the drug (including toluidine and guaiac resin for determining hemoglobin or glucose in stool or urine).
- When using the drug, the uptake of iodine by the thyroid gland may be reduced. This can lead to disruptions in thyroid scintigraphy, PBI(protein-bound iodine) determination and radio-iodine diagnostics and make planned radio-iodine treatment impossible.

Incompatibilities:
- The active ingredient is incompatible with reducing substances, alkaloid salts, tannic acid, salicylic acid, silver, mercury and bismuth salts, taurolidine, hydrogen peroxide.

Manufacturer:  B. Braun Melsungen AG, Carl-Braun-Straße 1